HDAC5/KLF2 AXIS REGULATES NLRP3 MEDIATED RENAL INFLAMMATION AND FIBROSIS ASSOCIATED WITH NEPHROCALCINOSIS-RELATED CHRONIC KIDNEY DISEASE

被引：0
|
作者：
Pravesh, Sharma [1 ]
Karnam, Kalyani [1 ]
Sedmaki, Kavita [1 ]
Hira, Kirti [1 ]
Kulkarni, Onkar Prakash [1 ]
机构：
[1] Birla Inst Technol & Sci, Deparment Pharm, Hyderabad, India
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
P0684
引用
收藏
页码：1006 / 1006
页数：1
相关论文
共 16 条
  • [1] The macrophage phenotype and inflammasome component NLRP3 contributes to nephrocalcinosis-related chronic kidney disease independent from IL-1-mediated tissue injury
    Anders, Hans-Joachim
    Suarez-Alvarez, Beatriz
    Grigorescu, Melissa
    Foresto-Neto, Orestes
    Steiger, Stefanie
    Desai, Jyaysi
    Marschner, Julian A.
    Honarpisheh, Mohsen
    Shi, Chongxu
    Jordan, Jutta
    Mueller, Lisa
    Burzlaff, Nicolai
    Baeuerle, Tobias
    Mulay, Shrikant R.
    KIDNEY INTERNATIONAL, 2018, 93 (03) : 656 - 669
  • [2] The NLRP3 inflammasome is a potential target of ozone therapy aiming to ease chronic renal inflammation in chronic kidney disease
    Yu, Gang
    Bai, Zhiming
    Chen, Zhiyuan
    Chen, Hui
    Wang, Guoren
    Wang, Gang
    Liu, Zhenxiang
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2017, 43 : 203 - 209
  • [3] HDAC5 RNA interference ameliorates acute renal injury by upregulating KLF2 and inhibiting NALP3 expression in a mouse model of oxalate nephropathy
    Sharma, Pravesh
    Karnam, Kalyani
    Mahale, Ashutosh
    Sedmaki, Kavitha
    Venuganti, Vamsi Krishna
    Kulkarni, Onkar Prakash
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 112
  • [4] ChREBP Deficiency Suppresses Renal Inflammation and Fibrosis Via Inhibiting NLRP3 Inflammasome Activation in Diabetic Kidney Disease
    Chen, Nan
    Yang, Zhifen
    Mu, Lin
    Wu, Ming
    Song, Jing
    Zhou, Tengxiao
    Shi, Yonghong
    DISCOVERY MEDICINE, 2022, 33 (169) : 69 - 83
  • [5] Fucoidan Alleviates Renal Fibrosis in Diabetic Kidney Disease via Inhibition of NLRP3 Inflammasome-Mediated Podocyte Pyroptosis
    Wang, Mei-Zi
    Wang, Jie
    Cao, Dong-Wei
    Tu, Yue
    Liu, Bu-Hui
    Yuan, Can-Can
    Li, Huan
    Fang, Qi-Jun
    Chen, Jia-Xin
    Fu, Yan
    Wan, Bing-Ying
    Wan, Zi-Yue
    Wan, Yi-Gang
    Wu, Guo-Wen
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [6] NLRP3 Deficiency Attenuates Renal Fibrosis and Ameliorates Mitochondrial Dysfunction in a Mouse Unilateral Ureteral Obstruction Model of Chronic Kidney Disease
    Guo, Honglei
    Bi, Xiao
    Zhou, Ping
    Zhu, Shijian
    Ding, Wei
    MEDIATORS OF INFLAMMATION, 2017, 2017
  • [7] TIMP2 protects against sepsis-associated acute kidney injury by cAMP/NLRP3 axis-mediated pyroptosis
    Xu, Dongxue
    Jiang, Jun
    Liu, Ye
    Pang, Jingjing
    Suo, Jinmeng
    Li, Yiming
    Peng, Zhiyong
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2024, 326 (05): : C1353 - C1366
  • [8] Bushen Huoxue formula protects against renal fibrosis and pyroptosis in chronic kidney disease by inhibiting ROS/NLRP3-mediated inflammasome activation
    Liao, Lin
    Tao, Pengyu
    Xu, Qiming
    Chen, Jie
    Liu, Weiwei
    Hu, Jing
    Lu, Jianrao
    RENAL FAILURE, 2024, 46 (01)
  • [9] Shen Shuai IIRecipe attenuates renal injury and fibrosis in chronic kidney disease by regulating NLRP3 inflammasome and Sirt1/Smad3 deacetylation pathway
    Meng Wang
    Liuyi Yang
    Jing Yang
    Chen Wang
    BMC Complementary and Alternative Medicine, 19
  • [10] Shen Shuai IIRecipe attenuates renal injury and fibrosis in chronic kidney disease by regulating NLRP3 inflammasome and Sirt1/Smad3 deacetylation pathway
    Wang, Meng
    Yang, Liuyi
    Yang, Jing
    Wang, Chen
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2019, 19 (1):
12